Aileen Wang
Director of Finance/CFO at CLOVER BIOPHARMACEUTICALS, LTD.
Profile
Aileen Wang is currently the Chief Financial Officer at Clover Biopharmaceuticals Ltd.
She previously worked at Novartis Gene Therapies, Inc. as the Head-Core Business Planning & Analysis.
Ms. Wang holds an MBA from The Pennsylvania State University and an undergraduate degree from Shanghai Jiao Tong University.
Aileen Wang active positions
| Companies | Position | Start |
|---|---|---|
| CLOVER BIOPHARMACEUTICALS, LTD. | Director of Finance/CFO | 30/06/2022 |
Former positions of Aileen Wang
| Companies | Position | End |
|---|---|---|
| AVEXIS INC | Corporate Officer/Principal | - |
Training of Aileen Wang
| The Pennsylvania State University | Masters Business Admin |
| Shanghai Jiao Tong University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CLOVER BIOPHARMACEUTICALS, LTD. | Health Technology |
| Private companies | 1 |
|---|---|
Novartis Gene Therapies, Inc.
 Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Novartis Gene Therapies, Inc. developed gene therapies for patients and families devastated by rare and life-threatening neurological genetic diseases. The firm’s robust AAV-based pipeline is used to provide advance treatments for Rett syndrome and Friedreich’s ataxia. The company was founded by John D. Harkey, Jr., David G. Genecov and John A. Carbona on March 8, 2010 and was headquartered in Bannockburn, IL. | Health Technology |
- Stock Market
- Insiders
- Aileen Wang
